Bruker AXS Announces Closing of Acquisition of JUWE Combustion Analysis Business and Establishment of Elemental Analysis Center
February 04 2008 - 8:32AM
Business Wire
Bruker AXS GmbH announced today the closing of its acquisition of
JUWE Laborgeraete GmbH in Viersen, Germany. The renamed Bruker JUWE
GmbH will operate under its previous experienced management with a
focus on rapid growth in combustion analysis for metals analysis.
During 2008, Bruker JUWE will be relocated to Kalkar, Germany,
where together with spark-OES specialist Bruker Quantron, it will
be part of the new Bruker Elemental Analysis Center of Excellence.
JUWE has serviced, and later on developed, manufactured and sold
combustion analysis (CA) systems for elemental analysis since 1997,
primarily for the metal production, chemical and pharmaceutical
industries. JUWE�s high-quality CA products complement Bruker�s
X-ray fluorescence (XRF) and optical emission spectroscopy (OES)
product lines in the field of elemental analysis. ABOUT BRUKER
BIOSCIENCES (NASDAQ: BRKR) Bruker BioSciences Corporation in
Billerica, Massachusetts is the parent company of Bruker AXS Inc.,
Bruker Daltonics Inc. and Bruker Optics Inc. For more information:
www.bruker-biosciences.com CAUTIONARY STATEMENT OF BRUKER
BIOSCIENCES Any statements contained in this press release that do
not describe historical facts may constitute forward-looking
statements as that term is defined in the Private Securities
Litigation Reform Act of 1995. Any forward-looking statements
contained herein are based on current expectations, but are subject
to a number of risks and uncertainties. The factors that could
cause actual future results to differ materially from current
expectations include, but are not limited to, risks and
uncertainties relating to the integration of businesses we have
acquired or may acquire in the future, changing technologies,
product development and market acceptance of our products, the cost
and pricing of our products, manufacturing, competition, dependence
on collaborative partners and key suppliers, capital spending and
government funding policies, changes in governmental regulations,
intellectual property rights, litigation, and exposure to foreign
currency fluctuations. These and other factors are identified and
described in more detail in our filings with the SEC, including,
without limitation, our annual report on Form 10-K for the year
ended Dec. 31, 2006, our most recent quarterly reports on Form 10-Q
and our current reports on Form 8-K. We disclaim any intent or
obligation to update these forward-looking statements other than as
required by law.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024